Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06871358Completed
Randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: High-sensitivity C-reactive protein to Albumin Ratio at 3 days. Started Sep 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06871358.